Authorised Indian Distributor
Saxsons Group
New Delhi, India · Since 1997
Europrobe Gamma / Fluorescence is a dual-modality opto-nuclear intraoperative detection platform — a world-first single probe that carries both CdTe gamma detection (⁹⁹ᵐTc, ¹²⁵I, ¹¹¹In) and indocyanine-green (ICG) near-infrared fluorescence detection. Two probe geometries cover open (SOE 3214) and laparoscopic (SOE 3214-AF) workflows. Modality switching is foot-switch driven — no scrubbed-hand interaction with the console. Fluorescence detection works under normal OR lighting; no room blackout required. ICG sensitivity < 1 nmol. EU MDR Class IIa registered and FDA-registered. Distributed and supported in India by Saxsons Healthcare.
| Detection modalities | CdTe (gamma) + NIR fluorescence (ICG) |
| Fluorescence sensitivity | < 1 nmol ICG |
| Gamma energy range | 20–300 keV (optimum 20–170 keV) |
| Compatible isotopes | ⁹⁹ᵐTc · ¹²⁵I · ¹¹¹In |
| Modality control | Foot-switch — sterile, no console interaction |
| Operating light | Normal OR lighting; no blackout required |
| Probe library | SOE 3214 (open opto-nuclear, 12 mm Ø, 194 mm) · SOE 3214-AF (frontal laparoscopic, 12.2 mm Ø, 426 mm) |
| Probe material | Medical-grade stainless steel; ISO 10993-5 / -10 / -11 biocompatible |
| Sterility | Sterile single-use probe cover |
| Module dimensions | 55 mm (H) × 233 mm (W) × 270 mm (D); 1 kg |
| Console compatibility | Europrobe 3.2 console — fluorescence is an add-on module to the gamma platform |
| Power | Standard OR power; no specific installation requirements |
| Regulatory | EU MDR Class IIa (39483-0); FDA registered 9032627 |
Where dual gamma + ICG fluorescence beats either modality alone
Tc-99m-nanocolloid + ICG-99m hybrid tracer or sequential ICG injection. The dual probe finds the node by gamma signal at depth and by ICG fluorescence at the dissection plane. Published series report dual-modality detection rates approaching 100 % vs ~95 % for either modality alone.
Intradermal Tc-99m-nanocolloid + sub-dermal ICG at the primary site. Dual modality reduces the false-negative rate at multiple-basin and intransit drainage where gamma-only mapping can miss a faint node.
Para-cervical Tc-99m + ICG injection in cervical and endometrial cancer. The SOE 3214-AF frontal laparoscopic probe carries both channels through the standard 12 mm trocar — the surgeon does not swap to a separate fluorescence-only laparoscope.
Peri-tumour Tc-99m-nanocolloid + ICG injection in oral SCC; the dual channel discriminates ipsilateral level I-III nodes against a busy floor-of-mouth gamma background.
Threshold for detectable ICG fluorescence — comfortably below the working ICG concentration after standard pre-operative subcutaneous injection. The probe finds the node before the surgical-grade NIR camera does in the deep tissue plane.
Selection of detection modality through a foot-switch — no scrubbed-hand interaction with the console. Sterile workflow stays intact; the surgeon switches gamma ↔ fluorescence at the dissection cadence.
Fluorescence detection works under normal OR lighting — no room blackout required. The NIR wavelength is outside the visible spectrum; ambient overhead light does not saturate the channel.
Where dual modality is used
Eight surgical areas where the dual gamma + ICG fluorescence workflow has published evidence. Open SOE 3214 covers the breast / melanoma / head & neck / vulvar / inguinal / penile SLN; laparoscopic SOE 3214-AF covers pelvic and prostate / bladder SLN trans-trocar. Hover any marker for the probe image.
1 · Head & neck SLN
Oral SCC · ICG + Tc-99m peri-tumoural
Open · SOE 3214
2 · Axillary SLN — breast
Hybrid ICG-99mTc-nanocolloid · peri-areolar
Open · SOE 3214
3 · Melanoma SLN — skin
Multi-basin drainage · sub-dermal ICG + Tc-99m
Open · SOE 3214
4 · Inguinal SLN
Melanoma · penile · vulvar drainage
Open · SOE 3214
Head & neck SLN
Oral SCC · ICG + Tc-99m peri-tumoural
Open · SOE 3214
Axillary SLN — breast
Hybrid ICG-99mTc-nanocolloid peri-areolar
Open · SOE 3214
Melanoma SLN — skin
Sub-dermal ICG + Tc-99m at primary site
Open · SOE 3214
Pelvic SLN — cervix / endometrium
Laparoscopic / robotic · Tc-99m + ICG paracervical
Laparoscopic · SOE 3214-AF (trans-trocar)
Prostate / bladder SLN
Robotic / laparoscopic urology · Tc-99m + ICG
Laparoscopic · SOE 3214-AF (trans-trocar)
Vulvar SLN
Early vulvar cancer · Tc-99m + ICG peri-tumour
Open · SOE 3214
Penile SLN
Penile cancer · intradermal Tc-99m + ICG
Open · SOE 3214
Inguinal SLN
Melanoma · penile · vulvar drainage
Open · SOE 3214
5 · Pelvic SLN — cervix / endometrium
Laparoscopic / robotic · paracervical injection
Laparoscopic · SOE 3214-AF
6 · Vulvar SLN
Early vulvar cancer · Tc-99m + ICG peri-tumour
Open · SOE 3214
7 · Penile SLN
Penile cancer · intradermal Tc-99m + ICG
Open · SOE 3214
8 · Prostate / bladder SLN
Robotic / laparoscopic urology · Tc-99m + ICG
Laparoscopic · SOE 3214-AF
Both probes carry both channels
CdTe gamma (20–300 keV) + NIR ICG fluorescence (< 1 nmol) — foot-switch toggled · normal OR light
Add-on to Europrobe 3.2 console
Same console as the gamma-only platform; fluorescence module is the upgrade path
Probe geometries
Two dual-channel probe geometries cover the open and laparoscopic OR workflow. Both carry the CdTe gamma channel AND the NIR ICG fluorescence channel in the same probe body.
| Model | Geometry | Size | Use |
|---|---|---|---|
| SOE 3214 | Standard opto-nuclear | 12 mm Ø · 194 mm length | Open SLN — breast, melanoma, head & neck. Single probe carries both CdTe gamma and NIR fluorescence channels. |
| SOE 3214-AF | Frontal laparoscopic opto-nuclear | 12.2 mm Ø · 426 mm length | Trans-trocar SLN for gynaecological + urological robotic / laparoscopic cases. Frontal-tip both-channel detection. |
What the dual platform brings
| Capability | Why it matters in theatre |
|---|---|
| Single dual-channel probe per case | One probe, one cable, one sterile cover — both gamma + ICG fluorescence detection from the same body. No probe-swap mid-case; sterile field stays intact. |
| Foot-switch modality control | Surgeon stays scrubbed; the foot-switch toggles gamma ↔ fluorescence without breaking the dissection cadence. |
| Works under normal OR lighting | NIR fluorescence channel is outside the visible spectrum; no room blackout required. OR list stays on schedule; nursing-circulator stress goes down. |
| Same console as Europrobe 3.2 gamma platform | The fluorescence module is an add-on to the Europrobe 3.2 console. A hospital that already runs a gamma-only Europrobe upgrades to dual-modality without replacing the platform. |
| Standard CdTe energy range | 20–300 keV gamma window (optimum 20–170 keV) covers ⁹⁹ᵐTc, ¹²⁵I, ¹¹¹In — the same workhorse range as the gamma-only platform. |
| Sterile single-use probe cover | Biocompatible cover ISO 10993 compliance; standard sterile field maintained across the dual-channel probe geometry. |
Product brochure, AERB radioisotope-handling framework and CDSCO ICG reference
Dual opto-nuclear probe specifications, ICG sensitivity, probe geometries and accessory matrix.
Indian regulatory framework — pre-operative ⁹⁹ᵐTc injection authorisation, theatre handling and specimen-disposal expectations.
Central Drugs Standard Control Organisation reference for ICG as the operative fluorescence agent.
Europrobe™ Gamma + Fluorescence
Each card opens a focused post for a specific specialty — peer-reviewed evidence and clinical workflow, written for the persona you select.
Contact Saxsons Healthcare for probe-geometry selection per OR list (open vs laparoscopic), sterile-cover quantities, installation as an add-on to an existing Europrobe 3.2 console, training, AMC and warranty — distributed and supported across India.